Completed PHASE4 INTERVENTIONAL 2-arm NCT02551536

Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis

Comparison of Efficacy, Safety and Cost Effectiveness of Montelukast and Levocetirizine Versus Montelukast and Fexofenadine in Patients of Allergic Rhinitis: a Randomized, Double-blind Clinical Trial

Sponsor: Indira Gandhi Medical College, Shimla

Conditions Allergic Rhinitis

Interventions Fexofenadine Levocetrizine Montelukast

Updated 7 times since 2017 Last updated: Sep 15, 2015 Started: Apr 30, 2014 Primary completion: Apr 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Allergic Rhinitis and is currently completed. Indira Gandhi Medical College, Shimla leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Nov 2019 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indira Gandhi Medical College, Shimla

Data source: Indira Gandhi Medical College, Shimla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.